PATENT CLAIM ANALYSIS

Application Number: 15866444
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "341000"]

Abstract:
The present invention relates to compounds of formula I wherein R 1′  is CH 3 ; R 1  is methyl, ethyl, CF 3 , CH 2 OH, cyclopropyl or cyano, or      R 1′  and R 1  may form together a 1,1-dioxo-tetrahydro-thiophen-3-yl ring;       R 2  is hydrogen, methyl, ethyl, isopropyl, tertbutyl, cyclopropyl, hydroxmethyl, or 2-propyl-2-ol; R 3  is Cl, F, CF 3 , methyl, methoxy, isopropyl, cyano or cyclopropyl; R 4  is hydrogen, methyl, F or Cl; or to a pharmaceutically acceptable salt or acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof.  The compounds of formula I may be used in the treatment of psychiatric disorders such as schizophrenia, bipolar disorder, obsessive-compulsive disorder or autism spectrum disorder.

Claim (Index 4):
The compound according to  claim 1  of formula IB, wherein R 2  is hydrogen, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, hydroxmethyl, or 2-propyl-2-ol; R 3  is Cl, F, CF 3 , methyl, methoxy, isopropyl, cyano or cyclopropyl; R 4  is hydrogen, methyl, F or Cl; or a pharmaceutically acceptable salt or acid addition salt thereof.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 2.10959
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15830399', '15569349', '14765552', '14169642', '14204934']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7695504740693478
- 35 USC 102 Novelty (BERT): 0.5855037615526153
- Combined Prediction Score: 0.7511458028176745
- Mean Citation Score: 357.708714
- Max Citation Score: 463.1303
- Similarity Product: 445.9395176875829

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test